Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahmoud Aljurf

Showing results (261-270 of 403) with videos related to

Pageof 41
Sort By:
Bone Marrow Transplantation|June 4, 2024
Prognostic factors impacting post-transplant outcomes in adult T-cell acute lymphoblastic leukemia: a registry-based study by the EBMT acute leukemia working partyJean El Cheikh, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Transplantation and Cellular Therapy|October 2, 2023
Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)Guillermo Ortí, Luuk Gras, Linda Koster, et al.
Bone Marrow Transplantation|February 20, 2019
"Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries"Mahmoud Aljurf, Daniel Weisdorf, Feras Alfraih, et al.
Haematologica|September 23, 2017
CD56<sup>bright</sup> natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-<i>versus</i>-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study resultsAmina Kariminia, Sabine Ivison, Bernard Ng, et al.
Bone Marrow Transplantation|April 22, 2025
Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert groupMarion Larue, Florent Malard, Ahmed S Alaskar, et al.
Bone Marrow Transplantation|January 14, 2018
Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMTSimone Cesaro, Roberto Crocchiolo, Gloria Tridello, et al.
JAMA Oncology|June 5, 2020
Association of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic TransplantNilanjan Ghosh, Sairah Ahmed, Kwang Woo Ahn, et al.
The Lancet. Haematology|December 22, 2015
One million haemopoietic stem-cell transplants: a retrospective observational studyAlois Gratwohl, Marcelo C Pasquini, Mahmoud Aljurf, et al.
Bone Marrow Transplantation|April 29, 2025
Outcomes of human leukocyte antigen matched sibling transplant from consanguineous versus non-consanguineous parents, a single center experienceRiad El Fakih, Mohamed I Sharif, Shaykhah Alotaibi, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2025
Prognostic Factors and Real-World Outcomes in Adolescents and Young Adults (AYA) With Philadelphia-Negative Acute Lymphoblastic Leukemia (ALL) Treated With the AYA-15 Protocol: A Retrospective Cohort Study From a Tertiary Care Referral Center in the Middle EastAmr Hanbali, Ayman Saad, Syed Osman Ahmed, et al.
Pageof 41

Showing results (261-270 of 403) with videos related to

Sort By:
Pageof 41
Bone Marrow Transplantation|June 4, 2024
Prognostic factors impacting post-transplant outcomes in adult T-cell acute lymphoblastic leukemia: a registry-based study by the EBMT acute leukemia working partyJean El Cheikh, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Transplantation and Cellular Therapy|October 2, 2023
Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)Guillermo Ortí, Luuk Gras, Linda Koster, et al.
Bone Marrow Transplantation|February 20, 2019
"Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries"Mahmoud Aljurf, Daniel Weisdorf, Feras Alfraih, et al.
Haematologica|September 23, 2017
CD56<sup>bright</sup> natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-<i>versus</i>-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study resultsAmina Kariminia, Sabine Ivison, Bernard Ng, et al.
Bone Marrow Transplantation|April 22, 2025
Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert groupMarion Larue, Florent Malard, Ahmed S Alaskar, et al.
Bone Marrow Transplantation|January 14, 2018
Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMTSimone Cesaro, Roberto Crocchiolo, Gloria Tridello, et al.
JAMA Oncology|June 5, 2020
Association of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic TransplantNilanjan Ghosh, Sairah Ahmed, Kwang Woo Ahn, et al.
The Lancet. Haematology|December 22, 2015
One million haemopoietic stem-cell transplants: a retrospective observational studyAlois Gratwohl, Marcelo C Pasquini, Mahmoud Aljurf, et al.
Bone Marrow Transplantation|April 29, 2025
Outcomes of human leukocyte antigen matched sibling transplant from consanguineous versus non-consanguineous parents, a single center experienceRiad El Fakih, Mohamed I Sharif, Shaykhah Alotaibi, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2025
Prognostic Factors and Real-World Outcomes in Adolescents and Young Adults (AYA) With Philadelphia-Negative Acute Lymphoblastic Leukemia (ALL) Treated With the AYA-15 Protocol: A Retrospective Cohort Study From a Tertiary Care Referral Center in the Middle EastAmr Hanbali, Ayman Saad, Syed Osman Ahmed, et al.
Pageof 41